EVOLIZEDIGITAL RISK INTELLIGENCE
RUN FREE ASSESSMENT
RUN FREE ASSESSMENT
Public accessibility assessment

Accessibility issues detected on fightcancer.org

Evolize inspected 5 public pages on fightcancer.org and detected 54 automatically identifiable accessibility findings.

54Findings detected
6WCAG criteria affected
5Pages inspected
9 Sep 2026Assessment date

Highest detected severity: Critical · 11 high-priority findings · 100% inspected-page coverage

Most widespread issueHidden elements can still receive keyboard focusDetected on 5 inspected pages
Most affected page/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-024 findings detected
Most represented WCAG criterionWCAG 1.4.3 — Contrast (Minimum)35 detected findings

Is fightcancer.org your website?

Keep this assessment current and get notified when new accessibility issues are detected.

ACTIVATE MONITORINGRUN A FREE ASSESSMENT
https://

Not your website? Scan your own site →

01 · Accessibility summary

Evolize inspected 5 public pages on fightcancer.org and detected 54 accessibility findings. The most widespread issue was "Hidden elements can still receive keyboard focus", detected on 5 inspected pages. The most affected inspected page was "/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0", where 24 findings were detected. The assessment identified findings mapped to 6 WCAG success criterions. The sections below prioritize the broadest issues and provide technical evidence for each detected finding.

02 · Start here

These findings combine the highest severity and broadest reach detected during this assessment.

  1. Critical

    Links lack accessible text

    WCAG 2.4.4 (A) · 1 inspected page · 2 instances
    Why this matters

    Links expose no accessible name, so screen-reader users cannot determine their destination.

    Recommended action

    This link exposes no accessible text. Add visible text that identifies its destination, or remove the link if it serves no purpose. For an icon-only link, provide an aria-label describing where it goes. The link points to https://act.fightcancer.org/a/2026-lights-hope?=&ms=fundraising_LOH1_web_ho….

    View technical evidence →
  2. Critical

    Links lack accessible text

    WCAG 2.4.4 (A) · 1 inspected page · 2 instances
    Why this matters

    Links expose no accessible name, so screen-reader users cannot determine their destination.

    Recommended action

    This link exposes no accessible text. Add visible text that identifies its destination, or remove the link if it serves no purpose. For an icon-only link, provide an aria-label describing where it goes. The link points to https://act.fightcancer.org/a/congress-protect-and-increase-funding-lifesaving-….

    View technical evidence →
  3. Critical

    Embedded frames lack descriptive titles

    WCAG 4.1.2 (A) · 1 inspected page · 1 instance
    Why this matters

    An <iframe> has no title, so its purpose is not announced to assistive technology.

    Recommended action

    Add a concise title attribute that describes the frame's actual purpose — for example "Store locator" for a location search or "Promotional campaign" for a marketing embed. The affected frame loads /splashify-splash, which can help identify its purpose. Avoid generic values such as "Embedded content", "iframe", or "frame".

    View technical evidence →
  4. Critical

    Links lack accessible text

    WCAG 2.4.4 (A) · 1 inspected page · 1 instance
    Why this matters

    Links expose no accessible name, so screen-reader users cannot determine their destination.

    Recommended action

    This link exposes no accessible text. Add visible text that identifies its destination, or remove the link if it serves no purpose. For an icon-only link, provide an aria-label describing where it goes. The link points to https://act.fightcancer.org/a/congress-protect-and-increase-funding-lifesaving-….

    View technical evidence →
  5. Critical

    Links lack accessible text

    WCAG 2.4.4 (A) · 1 inspected page · 1 instance
    Why this matters

    Links expose no accessible name, so screen-reader users cannot determine their destination.

    Recommended action

    This link exposes no accessible text. Add visible text that identifies its destination, or remove the link if it serves no purpose. For an icon-only link, provide an aria-label describing where it goes. The link points to https://act.fightcancer.org/a/2026-lights-hope?=&amp;ms=fundraising_LOH1_web_ho….

    View technical evidence →

03 · WCAG criteria affected

CriterionNameLevelFindingsPagesReach
1.4.3Contrast (Minimum)AA3555 / 5
2.4.3Focus OrderA955 / 5
2.4.4Link Purpose (In Context)A411 / 5
1.3.1Info and RelationshipsA355 / 5
4.1.2Name, Role, ValueA211 / 5
2.1.1KeyboardA155 / 5

Absence of a criterion here does not indicate conformance with it — only that no automatically detectable issue was found for it.

Continuous monitoring

A scan shows today's exposure. Monitoring shows what changes next.

Evolize continuously reassesses public website pages, detects newly introduced or recurring accessibility findings, and tracks remediation over time.

ACTIVATE MONITORINGSEE PRICING

04 · All detected findings

Critical

Embedded frames lack descriptive titles

WCAG 4.1.2 (A)1 instance1 inspected page

An <iframe> has no title, so its purpose is not announced to assistive technology.

Why it matters

An <iframe> has no title, so its purpose is not announced to assistive technology.

Recommended correction

Add a concise title attribute that describes the frame's actual purpose — for example "Store locator" for a location search or "Promotional campaign" for a marketing embed. The affected frame loads /splashify-splash, which can help identify its purpose. Avoid generic values such as "Embedded content", "iframe", or "frame".

View 1 affected element
Component · Ref 4XB3KT
Affected pagehttps://www.fightcancer.org/
Element.cboxIframe
Markup
<iframe frameborder="0" name="1788963358031" src="/splashify-splash" class="cboxIframe"></iframe>
High

Hidden elements can still receive keyboard focus

WCAG 2.4.3 (A)50 instances5 inspected pages

An element is not visible but remains in the tab order, so a sighted keyboard user loses track of focus when it lands there.

Why it matters

An element is not visible but remains in the tab order, so a sighted keyboard user loses track of focus when it lands there.

Recommended correction

Keep this element out of the tab order while its containing region is hidden — remove it from focus (for example tabindex="-1"), or apply the inert attribute to the hidden container where supported. Restore normal focusability when the region becomes visible.

View 50 affected elements
Component · Ref 29HDFZ
Affected pagehttps://www.fightcancer.org/contact-lsld-staff
Elementbutton#cboxSlideshow
Markup
<button id="cboxSlideshow"></button>
Affected pages/ /contact-lsld-staff /policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0 /policy-resources/prevention-and-early-detection-tobacco/regulation-and-products /releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Component · Ref 8Z14BQ
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Elementinput#email-address
Accessible nameEnter Your Email Address
Markup
<input type="email" name="primary_email" class="email-input form-input" id="email-address" placeholder="Enter Your Email Address" data-acs-can-email-signup-input="" aria-label="Enter Your Email Address">
Affected pages/ /contact-lsld-staff /policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0 /policy-resources/prevention-and-early-detection-tobacco/regulation-and-products /releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Component · Ref 379I2G
Affected pagehttps://www.fightcancer.org/releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Elementsection#block-locale-language-content > ul > li:nth-of-type(1) > a
Accessible nameEnglish
Markup
<a href="/releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products" class="language-link active" xml:lang="en">English</a>
Affected pages/ /policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0 /policy-resources/prevention-and-early-detection-tobacco/regulation-and-products /releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Component · Ref 6BTL2J
Affected pagehttps://www.fightcancer.org/policy-resources/prevention-and-early-detection-tobacco/regulation-and-products
Elementform#acs-can-header-signup-block > button
Accessible nameSubmit
Markup
<button type="submit" class="email-submit form-submit" aria-label="Submit"><span class="icon fa fa-arrow-right" aria-hidden="true"></span></button>
Affected pages/ /policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0 /policy-resources/prevention-and-early-detection-tobacco/regulation-and-products /releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Component · Ref 9Q03QJ
Affected pagehttps://www.fightcancer.org/
Elementdiv > div > div:nth-of-type(2) > div > div > a
Markup
<a href="https://act.fightcancer.org/a/2026-lights-hope?=&amp;ms=fundraising_LOH1_web_home_hero">
  </a>
Component · Ref A5SV4B
Affected pagehttps://www.fightcancer.org/contact-lsld-staff
Elementdiv#ot-desc-id-C0001 > div:nth-of-type(2) > button
Accessible nameStrictly Necessary Cookies - Vendor Details button opens Vendor List menu
Markup
<button class="ot-link-btn category-host-list-handler" aria-label="Strictly Necessary Cookies - Vendor Details button opens Vendor List menu" data-parent-id="C0001">View Vendor Details‎</button>
Component · Ref CH7YAW
Affected pagehttps://www.fightcancer.org/contact-lsld-staff
Elementp#ot-pc-desc > a
Accessible nameMore information about your privacy, opens in a new tab
Markup
<a href="https://cookiepedia.co.uk/giving-consent-to-cookies" class="privacy-notice-link" rel="noopener" target="_blank" aria-label="More information about your privacy, opens in a new tab">More information</a>
Component · Ref C47DA6
Affected pagehttps://www.fightcancer.org/contact-lsld-staff
Elementdiv#ot-pc-content > div:nth-of-type(2) > div:nth-of-type(1) > ul > li:nth-of-type(1) > div
Accessible nameYour Privacy
Roletab
Markup
<div class="ot-active-menu category-menu-switch-handler" role="tab" tabindex="0" aria-selected="true" aria-controls="ot-tab-desc"><h3 id="ot-pvcy-txt">Your Privacy</h3></div>
Component · Ref 7FMTL6
Affected pagehttps://www.fightcancer.org/contact-lsld-staff
Elementdiv#ot-tab-desc
Accessible nameYour Privacy
Roletabpanel
Markup
<div class="ot-desc-cntr" id="ot-tab-desc" tabindex="0" role="tabpanel" aria-labelledby="ot-pvcy-hdr"><h4 id="ot-pvcy-hdr">Your Privacy</h4><p id="ot-pc-desc" class="ot-grp-desc">When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences, or your device, and is mostly used to make the site work as you expect. The information does not usually identify you directly, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow…
High

Interactive controls are not keyboard-accessible

WCAG 2.1.1 (A)20 instances5 inspected pages

A control that responds to clicks (a clickable element or an ARIA widget) cannot receive keyboard focus, so keyboard and switch users cannot operate it.

Why it matters

A control that responds to clicks (a clickable element or an ARIA widget) cannot receive keyboard focus, so keyboard and switch users cannot operate it.

Recommended correction

Use a native <button>/<a>, or add tabindex="0" plus keyboard event handlers (Enter/Space) to custom controls.

View 20 affected elements
Component · Ref V641T1
Affected pagehttps://www.fightcancer.org/
Elementdiv#ot-pc-content > div:nth-of-type(2) > div:nth-of-type(1) > ul > li:nth-of-type(4) > div
Accessible nameFunctional Cookies
Roletab
Markup
<div class="category-menu-switch-handler" role="tab" tabindex="-1" aria-selected="false" aria-controls="ot-desc-id-C0003"><h3 id="ot-header-id-C0003">Functional Cookies</h3></div>
Affected pages/ /contact-lsld-staff /policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0 /policy-resources/prevention-and-early-detection-tobacco/regulation-and-products /releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
High

Page has no main landmark

WCAG 1.3.1 (A)5 instances5 inspected pages

No <main> or role=main region is present, so screen reader users cannot jump to primary content.

Why it matters

No <main> or role=main region is present, so screen reader users cannot jump to primary content.

Recommended correction

Wrap the primary content in a single <main> element or role=main region.

View 5 affected elements
Component · Ref 4UAUOM
Affected pagehttps://www.fightcancer.org/releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Elementhtml > body
Accessible nameSkip to main content <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-N3X9GPV" height="0" width="0" style="display:none;visibility:hidden"></iframe> Press Room Public Policy Share Languages English Español X Search Donate Email Sign Up AboutOur OrganizationStaff & Board Careers Frequently Asked Questions Contact Us Volunteer Leadership Affinity Groups Our WorkReducing Health Disparities Where We Work Annual Reports & Financials Judicial Advocacy Initiative PrioritiesAccess to HealthcareAccess to Health Insurance Health Insurance Affordability Increasing and Protecting Access to Medicaid Access to Biomarker Testing Cancer PreventionBreast and Cervical Cancer Prostate Cancer Colorectal Cancer Multi-Cancer Early Detection Tests Healthy Eating and Active Living Cancer ResearchCancer Research Funding Clinical Trials Childhood Cancer Research Voices of Cancer Research Quality of LifePalliative Care Tobacco ControlTobacco Regulation and Products Smoke-Free Prevention and Cessation Tobacco Taxes Support Our WorkDonateMake a Donation Honor a Loved One Donate by Mail ACS CAN store Raise MoneyCreate my own event Honor or Memorial Volunteer Fundraising Toolkit MembershipJoin Membership Benefits Take ActionAdd Your VoiceGet Updates and Action Opportunities Volunteer in your Community Share Your Story Survivor Views FundraiseLights of Hope Cancer Votes College Advocacy Attend Events Select a State My State Select a State Search these items Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District Of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Go Press Room Share Facebook X LinkedIn Bluesky Share <!--//--><![CDATA[//><!-- if(window.da2a)da2a.script_load(); //--><!]]> All Press Releases Sept. 9 Deadline Arrives for Makers of E-Cigarettes and Other Tobacco Products to Apply to Keep Products on Market – FDA Must Protect Kids and Public Health Leading Health Groups call on FDA to Promptly Remove Products that Don’t Meet Deadline, Eliminate Flavored Products that Endanger Kids, and Require Rigorous Scientific Evidence of Public Health Benefit before Authorizing Any Products September 9, 2020 WASHINGTON, D.C. – Today, September 9, is the court-ordered deadline for manufacturers of e-cigarettes and certain other tobacco products to apply to the U.S. Food and Drug Administration to keep their products on the market. The following is a statement from the American Academy of Pediatrics, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids and Truth Initiative: With the September 9 deadline, the FDA has yet another opportunity to reverse the current epidemic of youth e-cigarette use and stop tobacco companies from addicting a new generation of kids with e-cigarettes, cigars and other tobacco products. The FDA must protect kids and public health, not the interests of the tobacco industry. Our organizations call on the FDA to take the following critical actions: The FDA must strongly enforce the September 9 deadline and promptly remove products that do not file the required applications by the deadline. To allow the public to assess industry compliance with, and FDA enforcement of, the deadline, the FDA should quickly follow through on its commitment to publish a list of tobacco products for which applications are submitted by the September 9 deadline. The FDA should not authorize the sale of any flavored tobacco products given the clear evidence that flavored products appeal to youth and have driven the youth e-cigarette epidemic. The FDA must require manufacturers to provide rigorous scientific evidence demonstrating that a product will actually benefit public health before authorizing its sale, as the law requires. Four long years after e-cigarettes, cigars and certain other tobacco products became subject to FDA oversight, manufacturers must finally obtain FDA authorization to continue selling these products. During those four years, youth e-cigarette use has skyrocketed to epidemic levels and millions of kids have been put at risk of nicotine addiction. The cause of this crisis is clear: tobacco companies have lured kids with appealing flavors and hooked them with massive doses of nicotine. The FDA must act decisively to stop them. To gain FDA authorization to market a new tobacco product, federal law (the 2009 Family Smoking Prevention and Tobacco Control Act) requires manufacturers to demonstrate that the product is “appropriate for the protection of the public health.” In enforcing this standard, our organizations have urged the FDA to apply the following key principles: The FDA should not authorize any product that will lead youth or other non-tobacco users to initiate use of the product.  Given the strong evidence that flavors attract youth and the lack of evidence that flavored products help smokers quit, no flavored tobacco product – including menthol-flavored products – can meet this test. Manufacturers must provide evidence that the product does not deliver nicotine at levels that increase the risk of abuse and addiction among youth. The FDA must require that manufacturers prove a product will predominantly be used by smokers who would otherwise continue smoking, that they …[truncated by Evolize: exceeded D1 value limit]
Markup
<body class="html not-front not-logged-in no-sidebars page-node page-node- page-node-145850 node-type-press-release i18n-en page-node--sept-9-deadline-arrives-for-makers-of-e-cigarettes-and-other-tobacco-products-to-apply-to-keep-products-on-market-–-fda-must-protect-kids-and-public-health" style="">
  <div id="skip-link">
    <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
  </div>
    <div class="region region-page-top">
    <noscript aria-hidden="true"><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-N3X9GPV" height="0" width="0" styl…
Affected pages/ /contact-lsld-staff /policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0 /policy-resources/prevention-and-early-detection-tobacco/regulation-and-products /releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Medium

Text has insufficient colour contrast

WCAG 1.4.3 (AA)99 instances5 inspected pages

Text and background colours do not meet the minimum contrast ratio, reducing legibility.

Why it matters

Text and background colours do not meet the minimum contrast ratio, reducing legibility.

Recommended correction

Increase the contrast ratio to at least 4.5:1 for normal text and 3:1 for large text.

View 99 affected elements
Component · Ref BCK4Y1
Affected pagehttps://www.fightcancer.org/contact-lsld-staff
Element#select2-chosen-2
Accessible name- Select -
Markup
<span class="select2-chosen" id="select2-chosen-2">- Select -</span>
Component · Ref 9PSCZS
Affected pagehttps://www.fightcancer.org/releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Element.even.field-item > p:nth-child(4)
Accessible nameFour long years after e-cigarettes, cigars and certain other tobacco products became subject to FDA oversight, manufacturers must finally obtain FDA authorization to continue selling these products. During those four years, youth e-cigarette use has skyrocketed to epidemic levels and millions of kids have been put at risk of nicotine addiction. The cause of this crisis is clear: tobacco companies have lured kids with appealing flavors and hooked them with massive doses of nicotine. The FDA must act decisively to stop them.
Markup
<p>
Affected pages/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0 /releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Component · Ref OSYOL9
Affected pagehttps://www.fightcancer.org/releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Elementh1
Accessible nameSept. 9 Deadline Arrives for Makers of E-Cigarettes and Other Tobacco Products to Apply to Keep Products on Market – FDA Must Protect Kids and Public Health
Markup
<h1 class="node-title">Sept. 9 Deadline Arrives for Makers of E-Cigarettes and Other Tobacco Products to Apply to Keep Products on Market – FDA Must Protect Kids and Public Health</h1>
Affected pages/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0 /releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Component · Ref 280WYR
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Element#edn7 > p
Accessible name[vii] Wharam JF, Zhang F, Lu CY, et al. Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment. J Clin Oncol. 2018;36(11):1121–1127. doi:10.1200/JCO.2017.75.2501
Markup
<p><a href="#_ednref7" name="_edn7" title="" id="_edn7">[vii]</a> Wharam JF, Zhang F, Lu CY, et al. Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment.&nbsp;J Clin Oncol. 2018;36(11):1121–1127. doi:10.1200/JCO.2017.75.2501</p>
Affected pages/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0 /releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Component · Ref OXPTQ8
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Element#edn3 > p > a:nth-child(2)
Accessible namewww.fightcancer.org/costsofcancer
Markup
<a href="https://www.fightcancer.org/costsofcancer">www.fightcancer.org/costsofcancer</a>
Affected pages/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0 /releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Component · Ref YB80WT
Affected pagehttps://www.fightcancer.org/policy-resources/prevention-and-early-detection-tobacco/regulation-and-products
Element.col-xs-12.col-md-4.col-lg-4:nth-child(1) > .node.node-resource.node-teaser > .field-name-body.field-type-text-with-summary.field > .field-name-body.field-type-text-with-summary.field > p:nth-child(2)
Accessible nameIn March 2026, FDA released the “Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications – Considerations Related to Youth Risk; Draft Guidance for Industry." Draft Guidance provides FDA's current thinking about the topic of the guidance. The undersigned public health, medical, civil righs and community organizations conclude that the Draft Guidance fails to recognize the well-established history of signficant variations in youth flavor preferences over time, often caused by regulatory decisions, and this fundamental flaw threatens to open the regulatory door to a wide array of FDA-authorized products that would appeal and be accessible to youth, without signficant countervailing health benefits to adults who smoke.
Markup
<p>
Component · Ref 4LKK9Q
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Element.field-item.even > div > ul > li:nth-child(3)
Accessible nameMonitor and track the size of deductibles and study the impact of these deductibles on enrollees’ access to care and health outcomes.
Markup
<li>Monitor and track the size of deductibles and study the impact of these deductibles on enrollees’ access to care and health outcomes.</li>
Component · Ref OXPTVH
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Elementa:nth-child(8)
Accessible nameRoss-Degnan D
Markup
<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Ross-Degnan%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21577162">Ross-Degnan D</a>
Component · Ref WOCNOQ
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Element#_edn3
Accessible name[iii]
Markup
<a href="#_ednref3" name="_edn3" title="" id="_edn3">[iii]</a>
Component · Ref TSM05Z
Affected pagehttps://www.fightcancer.org/releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Element.more-about-tags > a:nth-child(2)
Accessible nameTobacco Control
Markup
<a href="/press-room/priority/Tobacco-Control">Tobacco Control</a>
Component · Ref QQB4GF
Affected pagehttps://www.fightcancer.org/policy-resources/prevention-and-early-detection-tobacco/regulation-and-products
Element.pane-acs-can-custom-blocks-acs-can-taxonomy-parent-terms > ul > li:nth-child(1) > a
Accessible namePrevention and Early Detection
Markup
<a href="/policy-resources/prevention-and-early-detection">Prevention and Early Detection</a>
Component · Ref QPQ34I
Affected pagehttps://www.fightcancer.org/policy-resources/prevention-and-early-detection-tobacco/regulation-and-products
Element.col-xs-12.col-md-4.col-lg-4:nth-child(3) > .node.node-resource.node-teaser > .field-name-title.field-type-ds.field > .field-items > .field-item.even > h3 > a
Accessible nameThe Tobacco Industry is Not the Public Health Solution
Markup
<a href="/policy-resources/tobacco-industry-not-public-health-solution">The Tobacco Industry is Not the Public Health Solution</a>
Component · Ref KJ2JKQ
Affected pagehttps://www.fightcancer.org/policy-resources/prevention-and-early-detection-tobacco/regulation-and-products
Element.col-xs-12.col-md-4.col-lg-4:nth-child(3) > .node.node-resource.node-teaser > .field-name-post-date.field-type-ds.field > .field-items > .field-item.even
Accessible nameFebruary 9, 2023
Markup
<div class="field-item even">February 9, 2023</div>
Component · Ref JDICAE
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Element.field-item.even > div > p:nth-child(2) > em
Accessible nameWhat are the Concerns for Cancer Patients, Survivors, and Those at Risk?
Markup
<em>What are the Concerns for Cancer Patients, Survivors, and Those at Risk?</em>
Component · Ref CJPYW9
Affected pagehttps://www.fightcancer.org/releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Elementul:nth-child(6) > li:nth-child(4)
Accessible nameManufacturers must also demonstrate that using a product is significantly less harmful than using other tobacco products as actually used by consumers.
Markup
<li>Manufacturers must also demonstrate that using a product is significantly less harmful than using other tobacco products as actually used by consumers.</li>
Component · Ref 0C9DT5
Affected pagehttps://www.fightcancer.org/
Element.hero-wrapper.odd > .title > a
Accessible nameSaving lives from cancer
Markup
<a href="https://www.fightcancer.org/about">Saving lives from cancer</a>
Component · Ref 2FZIH2
Affected pagehttps://www.fightcancer.org/policy-resources/prevention-and-early-detection-tobacco/regulation-and-products
Element.container > .pane-title
Accessible nameRegulation and Products Resources:
Markup
<h3 class="pane-title">Regulation and Products Resources:</h3>
Component · Ref TW3OC6
Affected pagehttps://www.fightcancer.org/
Element.view-display-id-panel_pane_hero_home_left > .view-content > .hero-item.odd.first > .views-field-body.views-field > .field-content > .hero-wrapper > .body > a
Accessible nameYour dedication can be one of thousands of Lights of Hope shining across the country, each one representing a person, a family and a story. Honor or remember a loved one touched by cancer and dedicate a Light of Hope today.
Markup
<a href="https://act.fightcancer.org/a/2026-lights-hope?&ms=fundraising_LOH1_web_home_hero">
Component · Ref 7BY1PE
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Elementa[type="application/pdf; length=191473"]
Accessible nameDownload Factsheet - HDHPs and HSAs
Markup
<a href="https://www.fightcancer.org/sites/default/files/HDHPs%20Factsheet%20Updated%20Final%2011-10-20.pdf" type="application/pdf; length=191473" title="HDHPs Factsheet Updated 11-2-20.pdf">Download Factsheet - HDHPs and HSAs</a>
Component · Ref VNJWLV
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Element.views-row-1.views-row-odd.views-row-first > .views-field-name.views-field > .field-content > a
Accessible namePrivate Health Insurance
Markup
<a href="/policy-resources/access-health-care/private-health-insurance">Private Health Insurance</a>
Component · Ref OBYA80
Affected pagehttps://www.fightcancer.org/releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Element.field-content > a[href$="press-room"]
Accessible nameAll Press Releases
Markup
<a href="/landing-pages/press-room">All Press Releases</a>
Component · Ref 8D81YY
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Elementu
Accessible nameACS CAN Position
Markup
<u>ACS CAN Position</u>
Component · Ref Q9VDGA
Affected pagehttps://www.fightcancer.org/
Element.hero-wrapper.odd > .body > a
Accessible nameWe're working together with our volunteers to advocate for evidence-based public policies to reduce the cancer burden for everyone.
Markup
<a href="https://www.fightcancer.org/about">We're working together with our volunteers to advocate for evidence-based public policies to reduce the cancer burden for everyone.</a>
Component · Ref 4VAZZ5
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Element.policy-issue-label
Accessible namePublic Policy Issue
Markup
<label class="policy-issue-label vocabulary-label">Public Policy Issue</label>
Component · Ref QZL1S7
Affected pagehttps://www.fightcancer.org/policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0
Element.views-field-path > .field-content > a
Accessible nameAll Resources
Markup
<a href="/landing-pages/public-policy-resources">All Resources</a>

Showing 25 representative examples · 10 more affected elements not shown

Medium

Content sits outside any landmark region

WCAG 1.3.1 (A)5 instances5 inspected pages

Meaningful content is not contained in a landmark (header/nav/main/footer/aside), so assistive-technology users cannot reach it via landmark navigation.

Why it matters

Meaningful content is not contained in a landmark (header/nav/main/footer/aside), so assistive-technology users cannot reach it via landmark navigation.

Recommended correction

Wrap primary content in <main> and other regions in appropriate landmark elements.

View 5 affected elements
Component · Ref C5WVQ
Affected pagehttps://www.fightcancer.org/policy-resources/prevention-and-early-detection-tobacco/regulation-and-products
Elementhtml > body > div:nth-of-type(3) > div > section > div
Accessible namePublic Policy Resources Share Facebook X LinkedIn Bluesky Share <!--//--><![CDATA[//><!-- if(window.da2a)da2a.script_load(); //--><!]]> Prevention and Early Detection Tobacco Control Regulation and ProductsWe are working to ensure the law granting the U.S. Food and Drug Administration (FDA) the authority to regulate all tobacco products, including cigarettes, e-cigarettes, cigars and hookah is fully leveraged to protect children and adults.   Regulation and Products Resources: Tobacco Control Partners' Comments on FDA's Draft Guidance on Flavored E-cigarette PMTAsMay 12, 2026In March 2026, FDA released the “Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications – Considerations Related to Youth Risk; Draft Guidance for Industry." Draft Guidance provides FDA's current thinking about the topic of the guidance. The undersigned public health, medical, civil righs and community organizations conclude that the Draft Guidance fails to recognize the well-established history of signficant variations in youth flavor preferences over time, often caused by regulatory decisions, and this fundamental flaw threatens to open the regulatory door to a wide array of FDA-authorized products that would appeal and be accessible to youth, without signficant countervailing health benefits to adults who smoke. Tobacco Control Partners Comment Letter to FDA on Zyn's Modified Risk Tobacco Product ApplicationsMarch 9, 2026American Academy of Pediatrics, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, and Campaign for Tobacco-Free Kidsoppose orders authorizing this claim because Swedish Match has failed to meet the statutory standard for the following reasons:1. FDA’s past authorizations of a similar claim for General Snus should not determine whether the pending applications for ZYN nicotine pouches are granted because theTobacco Control Act requires product-specific analyses.2. Significant differences between ZYN and General Snus – in use rates, relevant toxicology, flavors, and marketing – clearly warrant different consideration.3. The applicant’s reliance on the “Swedish experience” is misleading and of limited relevance.4. The applicant did not submit sufficient data on consumer perception or behavior change related to the proposed modified risk claim and this specific product. The Tobacco Industry is Not the Public Health SolutionFebruary 9, 2023Big tobacco has a history of prioritizing corporate profits over people and communities burdened by tobacco-related illness and death. For decades, the tobacco industry has lied to specific communities and the public at large saying their products are not addictive, harmful or deadly. Tobacco manufacturers continue to create and flood the market with newly designed products they market as being less harmful and alternatives to quitting – a tactic that is not new.
Markup
<div>
                <a id="main-content"></a>
  <!--
                          <h1 class="page-header">Regulation and Products</h1>
                  -->
                                                                    <div class="region region-content">
    <section id="block-system-main" class="block block-system clearfix">

      
  <div class="panels-flexible-row panels-flexible-row-nodes_page_title_locked_content_center-2 panels-flexible-row-first clearfix ">
<div class="panels-flexible-region panels-flexible-region-nodes_page_title_locked_content_center-page_title panels-flexible-re…
Affected pages/ /contact-lsld-staff /policy-resources/high-deductible-health-plans-health-savings-accounts-and-cancer-patients-0 /policy-resources/prevention-and-early-detection-tobacco/regulation-and-products /releases/sept-9-deadline-arrives-makers-e-cigarettes-and-other-tobacco-products-apply-keep-products
Medium

IDs used in ARIA and labels must be unique

WCAG 4.1.2 (A)1 instance1 inspected page

IDs used in ARIA and labels must be unique

Why it matters

IDs used in ARIA and labels must be unique

Recommended correction

Review the affected element and correct the reported accessibility issue.

View 1 affected element
Component · Ref RPXZVY
Affected pagehttps://www.fightcancer.org/
Elementselect[aria-label="My State"]
Accessible nameMy State
Markup
<select class="ctools-jump-menu-select ctools-jump-menu-change use-select-2 form-control form-select select2-attach-processed ctools-jump-menu-processed" aria-label="My State" id="edit-jump" name="jump" tabindex="-1" title="Select a StateSelect a State" style="display: none;">
Low

Page has no level-one heading

WCAG 1.3.1 (A)1 instance1 inspected page

The page exposes no <h1>, so its topic is not conveyed in the heading structure.

Why it matters

The page exposes no <h1>, so its topic is not conveyed in the heading structure.

Recommended correction

Add a single descriptive <h1> that names the page's primary purpose.

View 1 affected element
Component · Ref 05UP01
Affected pagehttps://www.fightcancer.org/
Elementhtml > body
Accessible nameSkip to main content <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-N3X9GPV" height="0" width="0" style="display:none;visibility:hidden"></iframe> Press Room Public Policy Share Languages English Español X Search Donate Email Sign Up AboutOur OrganizationStaff & Board Careers Frequently Asked Questions Contact Us Volunteer Leadership Affinity Groups Our WorkReducing Health Disparities Where We Work Annual Reports & Financials Judicial Advocacy Initiative PrioritiesAccess to HealthcareAccess to Health Insurance Health Insurance Affordability Increasing and Protecting Access to Medicaid Access to Biomarker Testing Cancer PreventionBreast and Cervical Cancer Prostate Cancer Colorectal Cancer Multi-Cancer Early Detection Tests Healthy Eating and Active Living Cancer ResearchCancer Research Funding Clinical Trials Childhood Cancer Research Voices of Cancer Research Quality of LifePalliative Care Tobacco ControlTobacco Regulation and Products Smoke-Free Prevention and Cessation Tobacco Taxes Support Our WorkDonateMake a Donation Honor a Loved One Donate by Mail ACS CAN store Raise MoneyCreate my own event Honor or Memorial Volunteer Fundraising Toolkit MembershipJoin Membership Benefits Take ActionAdd Your VoiceGet Updates and Action Opportunities Volunteer in your Community Share Your Story Survivor Views FundraiseLights of Hope Cancer Votes College Advocacy Attend Events Select a State My State Select a StateSelect a State Search these items Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District Of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Go Honor a loved one with Lights of Hope Your dedication can be one of thousands of Lights of Hope shining across the country, each one representing a person, a family and a story. Honor or remember a loved one touched by cancer and dedicate a Light of Hope today. Saving lives from cancer We're working together with our volunteers to advocate for evidence-based public policies to reduce the cancer burden for everyone. See how you can help Caroline is living proof that cancer research saves lives. Caroline's life was saved due to a surgical technique made possible by cancer research. Sign the petition and urge Congress to increase cancer research funding. Join us! We can't end cancer without your help! Take Action Become a Cancer Votes Ambassador today! Build your advocacy skills, engage directly with candidates in your area, and help make cancer a priority in this election by becoming a Cancer Votes ambassador. Sign Up Today More Actions Cancer Research Funding Access to Healthcare Breast and Cervical Cancer Colorectal Cancer Select a State My State Select a StateSelect a State Search these items Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District Of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana National Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Go Latest Updates See More Updates ACS CAN Calls on Congress to Pass Full-Year Budget; Preserve Stability in Federal Research FundingSeptember 1, 2026NationalToday, the House passed a continuing resolution (CR) to fund the f…[truncated by Evolize: exceeded D1 value limit]
Markup
<body class="html front not-logged-in no-sidebars page-node page-node- page-node-1 node-type-landing-page i18n-en page-node--home" style="">
  <div id="skip-link">
    <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
  </div>
    <div class="region region-page-top">
    <noscript aria-hidden="true"><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-N3X9GPV" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>  </div>
  <header role="banner" class="site-header">
  <div class="container-fluid">
    <div class="bann…

05 · Most affected inspected pages

06 · About this assessment

Evolize inspects publicly accessible website pages using automated browser-based testing and deterministic accessibility rules. Automated testing can identify many reproducible technical issues but cannot determine complete WCAG or legal compliance.

  • Publicly accessible surfaces only — no credentials, private systems, or source-code access.
  • Findings apply to the pages and states successfully inspected; automated analysis may not detect every issue.
  • Results reflect the site at the scan date and may have changed since.

Evolize provides digital risk intelligence and does not provide legal advice, certify compliance, or guarantee that litigation will not occur. Methodology · Security · Example assessment

07 · Continuous monitoring

This public report captures one assessment. Evolize monitoring rescans the website, detects new and recurring findings, tracks changes over time and verifies corrections.

ACTIVATE MONITORINGSEE PRICING

Is information in this report inaccurate or outdated? Request a correction or removal.